Peer Review History
| Original SubmissionAugust 10, 2022 |
|---|
|
PONE-D-22-22467Complications following transcutaneous cecal trocarization in horses with cattle trocar and cecal needlePLOS ONE Dear Dr. Dória, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 21 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript: A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Benito Soto-Blanco, DVM, MSc, PhD Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. As part of your revision, please complete and submit a copy of the Full ARRIVE 2.0 Guidelines checklist, a document that aims to improve experimental reporting and reproducibility of animal studies for purposes of post-publication data analysis and reproducibility: https://arriveguidelines.org/sites/arrive/files/documents/Author%20Checklist%20-%20Full.pdf Please include your completed checklist as a Supporting Information file. Note that if your paper is accepted for publication, this checklist will be published as part of your article. 3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for your work and your report on these 2 methods for cecal decompression in horses. Largely this study is well-conducted and the paper is well written. My biggest concern is the low number of subjects in a healthy population of horses that may make it challenging to broadly extrapolate to a larger population of sick horses with cecal distension. However, this is a great start and will serve as a foundation to more clinical studies. A few specific comments by line number follow: • Line 42: Peritonitis, even if not clinically detectable, could arguably still be considered a complication. If no horses had complications, then there should really be no difference between method of cecal decompression. I would specify that there were no clinically detectable complications. Or in line 455 you say 'no major complications' - I think that is appropriate. • Line 46: Please check, is there a scientific reason to not call this a 'fever'? • Line 81: 'causes more tissue damage'. It also causes a bigger hole for leakage. • Line 114: Here you say 'large intestinal trocarization' site. In other places (ex. line 120) you say 'cecal trocarization'. While both are correct, cecal tocarization is more precise and I would suggest you stay consistent throughout the manuscript. • Line 122: I would not say that 'and in which serial blood and peritoneal fluid samples were collected' here and when describing group 2 and the control group. Since sample collection was done the same for all groups, it would make it easier to read if you merely say this after describing all three groups. The reader will be able to focus on the differences between the groups. • Line 127: As horses were enrolled in the study, they were randomly assigned to one of the three treatment groups. I think this is a random crossover design. If so, please specify. • Line 136: Previously you used hyperthermia instead of 'pyrexia'. Please stay consistent. I would suggest 'pyrexia' or 'fever' unless you think that the increased temperature could be due to something else like increased ambient temperature. • Line 150: Should be 'a number 15 blade'. Not 'gauge'. • LIne 237: Best word choice? Hyperthermia, Pyrexia, or Fever? • Line 460-461: antimicrobials do not reduce abdominal contamination, they merely help to combat infection that results. • Discussion: I think it is also important to mention that these were healthy horses without cecal distension. Please comment in the discussion how the authors feel that horses with cecal tympany may be different which is the population of horses that this procedure would be performed on routinely. I would expect more leakage from around the cannula/needle since the gas is under more pressure. • Figure 1: The image on my PDF copy of the manuscript is blurry and it is difficult to see details. Hopefully this will be rectified in the final published copy. • Figure 2: I feel that this figure is nice to give a visual representation of how the peritoneal fluid changed over time. However the labels on the tubes are difficult to read in the photograph. I would recommend that text labels be added to the image over the respective tubes to indicate the time points at which these samples were drawn. (ex. T0, T2, T3, etc). • Perhaps consider adding some graphs (in addition to the tables) to show how the data compared for the three groups for some of the variables. Reviewer #2: The paper describes the potential for complications following transabdominal cecal trocharization of 6 healthy horses using a cecal needle or a cattle trocar. While only 6 horses were used the cross over study design with random assignment three month period of washout of control, cecal needle or cattle trocar appears suitable for interpretation of finding, and is in keeping with the principles of the 3 R’s. Horses were monitored for signed of clinically relevant peritonitis (CRP) and for a wide range of laboratory analyses both on blood and peritoneal fluid for clinical pathologic changes reflective of peritonitis. The study was clearly written and most procedure well described, with very good transparency of the results. The finding that both methods of cecal trocarization in normal healthy horses led to some degree of peritonitis based on laboratory but not CRP appear well substantiated. In most places within the manuscript please write “a needle trocar “ or “a cattle trocar”. The authors refer to many key scientific papers and hypothesis based studies that are highly relevant for this work. However, there are many references included that are largely book chapters or non peer reviewed works ( refs 5,7,8,9,11,12,20,21,22 among others) that do not appear essential to this work. My further comments and general critique are as below. Firstly, the authors describe the monitoring for CRP, with inclusion of use of both objective (heart rate (HR), respiratory rate (RR) temperature (ºC), and subjective (Pain assessment, general appearance, auscultation of gastrointestinal motility, and perfusion indices (mucous membrane color and capillary refill)). Was there any scoring system used for these subjective indices? In particular, how were pain, general appearance, intestinal motility assessed? For example, use of pain face in horses is now well accepted as a semiquantitative measure (see An equine pain face. Gleerup KB, Forkman B, Lindegaard C, Andersen PH. Vet Anaesth Analg. 2015 Jan;42(1):103-14. doi: 10.1111/vaa.12212. Epub 2014 Jul 31). Similarly, what criteria were used for ”general appearance” and can the authors clarify how the assessment of degree of intestinal motility was graded for comparison? These aspects should be more transparent, as the authors are suggesting that CRP did not occur in any of the horses, yet in the manuscript’s current form the reader must simply accept this conclusion despite incomplete evidence. The statistics used for this paper appear suitable but should be reviewed by another expert as I lack competence to make further comment. However presentation of confidence intervals would have been preferable to the SD used, as for example Table 8, the data as presented would suggest that for G2 ceruloplasmin was already higher at t=0 in comparison to CG. Please comment. Secondly, it would be importance within the discussion to address the aspect of the findings being relevant in normal healthy horses, and if they can be applicable to horses with colic that are deemed in need of cecal trocarization. In such cases, please also comment on the relevance of this study’s trocar size difference, and whether s gas removal from a severely distended cecum may be a factor to weigh in on the finding in this work. Other minor comments are as follows. Line 215 … blood cell count (< 5.5 x 103.. should be 103 Line 181 “Polyacrylamide Gel Electrophoresis” This section is heavy on laboratory analysis, but I would ask the authors what clinical significance it has for this study? Line 182 …were centrifuged at 3,000 rpm … please convert to x g Line 434. “It is known that cecal puncture promotes a solution of continuity with the abdominal cavity and represents a peritoneal insult”. Please reword, I am unsure what is meant by this. Line 439 “As demonstrated in this study, intense migration of neutrophils into the peritoneal cavity occurs due to the local release of chemotactic substances [32], which act in the primary cellular defense against microorganisms and have intense phagocytic activity [29]. “ As written this suggest that the work included measurement of chemotactic factors. Should rewrite to clarify only what the authors studied : Ie Migration of neutrophils into the peritoneal cavity as found in this study occurs due to the local release of chemotactic substances [32], which act in the primary cellular defense against microorganisms and have intense phagocytic activity [29]. Line 442: “Moreover, the increase of alkaline phosphatase enzyme in peritoneal fluid observed in this study is related to inflammatory processes and the presence of intestinal bacteria in the fluid [33,34]” As above, the authors did not assess for bacterial presence, and simply inflammation can have increase release of alkaline phosphatase, Suggest rephrasing as “Moreover, the increase of alkaline phosphatase enzyme in peritoneal fluid observed in this study was likely related to induction of an inflammatory processes due to trocarization and potentially the presence of intestinal bacteria in the fluid Lines 447-447 “Therefore, the results of this study show that serial abdominocentesis is not responsible for the increase in total proteins, total nucleated cells, and alkaline phosphatase in the peritoneal fluid. These particular findings are highly relevant clinically, and the authors deserve to highlight the finding more that just this one sentence. Line 471 “14 days of evaluation could be justified by the increase”… , rewrite to “14 days of evaluation could be explained by the increase… Line 478 …“once the horses.. change to …“ since the horses…” ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Andy Niehaus Reviewer #2: Yes: John Pringle DVM, PhD ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Complications following transcutaneous cecal trocarization in horses with a cattle trocar and a cecal needle PONE-D-22-22467R1 Dear Dr. Dória, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Benito Soto-Blanco, DVM, MSc, PhD Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Thank you for this manuscript. The authors have addressed my previous concerns with this manuscript. I feel that this is a nice study that will guide clinicians in making appropriate decisions regarding cecal trocarization in horses. Reviewer #2: Thank you for the response and revisions based on my and Reviewer #1 comments. My only query that remains is the ceruloplasmin where the data appear to suggest t=0 being markedly lower in the control group, much higher at the start for G1 and G2- while these still were not significantly higher at T= 24 and T=72 than their base lines. Thus I expect the reader to also question whether this "rise over time" -as found statistically- may have any underlying biologic relevance. Perhaps a comment within the discussion would be appropriate regarding the relative strength of evidence of these changes in relation to the many others (far more convincing- such as nucleated cells, neutrophils.. ). ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Andy Niehaus Reviewer #2: Yes: John Pringle ********** |
| Formally Accepted |
|
PONE-D-22-22467R1 Complications following transcutaneous cecal trocarization in horses with a cattle trocar and a cecal needle Dear Dr. Dória: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Benito Soto-Blanco Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .